Daniel L. Lorber

763 total citations
9 papers, 536 citations indexed

About

Daniel L. Lorber is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Nephrology. According to data from OpenAlex, Daniel L. Lorber has authored 9 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Daniel L. Lorber's work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Erythropoietin and Anemia Treatment (2 papers). Daniel L. Lorber is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Erythropoietin and Anemia Treatment (2 papers). Daniel L. Lorber collaborates with scholars based in United States, United Kingdom and India. Daniel L. Lorber's co-authors include William McClellan, Brian Wasserman, W. Kline Bolton, Sally A. Hood, Thomas F. Tse, Stephen Aronoff, K. Linda Tang, Anders Boss, Peter Richardson and Luigi Gnudi and has published in prestigious journals such as The Lancet, Diabetes Care and American Journal of Obstetrics and Gynecology.

In The Last Decade

Daniel L. Lorber

9 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Lorber United States 8 263 196 133 123 75 9 536
Melanie Blank United States 8 150 0.6× 165 0.8× 50 0.4× 58 0.5× 105 1.4× 13 441
Kunimi Maeda Japan 11 94 0.4× 131 0.7× 50 0.4× 61 0.5× 29 0.4× 35 359
F Gómez-Campderá Spain 12 110 0.4× 270 1.4× 68 0.5× 28 0.2× 78 1.0× 19 546
Giovanni Manca Rizza Italy 9 165 0.6× 398 2.0× 37 0.3× 45 0.4× 42 0.6× 11 639
Sabrina Paoletti Italy 14 162 0.6× 392 2.0× 29 0.2× 51 0.4× 64 0.9× 19 628
M Fusaroli Italy 9 68 0.3× 355 1.8× 75 0.6× 36 0.3× 78 1.0× 32 554
C Deighan United Kingdom 12 74 0.3× 173 0.9× 90 0.7× 38 0.3× 44 0.6× 15 421
Rubeen Israni United States 8 202 0.8× 234 1.2× 28 0.2× 89 0.7× 45 0.6× 16 413
Kai Uwe Eckardt Germany 7 70 0.3× 177 0.9× 34 0.3× 32 0.3× 31 0.4× 9 360
Petros Nikolopoulos Greece 6 260 1.0× 256 1.3× 22 0.2× 84 0.7× 24 0.3× 13 407

Countries citing papers authored by Daniel L. Lorber

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Lorber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Lorber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Lorber more than expected).

Fields of papers citing papers by Daniel L. Lorber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Lorber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Lorber. The network helps show where Daniel L. Lorber may publish in the future.

Co-authorship network of co-authors of Daniel L. Lorber

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Lorber. A scholar is included among the top collaborators of Daniel L. Lorber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Lorber. Daniel L. Lorber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lorber, Daniel L., Nuha A. ElSayed, Raveendhara R. Bannuru, et al.. (2024). Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association. Diabetes Care. 47(4). 544–555. 7 indexed citations
2.
Rosenstock, Julio, Daniel L. Lorber, Luigi Gnudi, et al.. (2010). Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. The Lancet. 375(9733). 2244–2253. 88 indexed citations
3.
Lorber, Daniel L., Robert Provenzano, & William McClellan. (2006). Prevalence and Treatment of Anemia With Once-Weekly Epoetin Alfa in Patients With Diabetes and Chronic Kidney Disease. Endocrine Practice. 12(5). 506–513. 7 indexed citations
4.
McClellan, William, Stephen Aronoff, W. Kline Bolton, et al.. (2004). The prevalence of anemia in patients with chronic kidney disease. Current Medical Research and Opinion. 20(9). 1501–1510. 348 indexed citations
5.
Lorber, Daniel L., et al.. (2001). Effect of Immediate Hemoglobin A1c Results on Treatment Decisions in Office Practice. Endocrine Practice. 7(2). 85–88. 36 indexed citations
6.
Lorber, Daniel L., et al.. (2001). Propylthiouracil-Induced Perinuclear-Staining Antineutrophil Cytoplasmic Autoantibody-Positive Vasculitis In Conjunction With Pericarditis. Endocrine Practice. 7(1). 37–39. 16 indexed citations
7.
Lorber, Daniel L., et al.. (1996). Phenformin-Associated Lactic Acidosis Due to Imported Phenformin. Diabetes Care. 19(12). 1449–1450. 9 indexed citations
8.
Tibaldi, Joseph M., et al.. (1990). Diabetic ketoacidosis and insulin resistance with subcutaneous terbutaline infusion: A case report. American Journal of Obstetrics and Gynecology. 163(2). 509–510. 22 indexed citations
9.
Lorber, Daniel L., T. J. McKenna, & D. Rabinowitz. (1978). PLASMA PREGNENOLONE AND 17-OH-PREGNENOLONE IN HIRSUTE AMENORRHOEIC PATIENTS. European Journal of Endocrinology. 87(3). 566–576. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026